METABOLISM IN VITRO OF SULINDAC. SULFOXIDE-REDUCING ENZYME SYSTEMS IN GUINEA PIG LIVER
-
- KITAMURA SHIGEYUKI
- Faculty of Pharmaceutical Sciences, Kyushu University (Present address)Research Laboratories. Nippon Merck-Banvu Co., Ltd.
-
- TATSUMI KIYOSHI
- Faculty of Pharmaceutical Sciences, Kyushu University
-
- YOSHIMURA HIDETOSHI
- Faculty of Pharmaceutical Sciences, Kyushu University
この論文をさがす
抄録
The sulfoxide reduction of sulindac (cis-5-fluoro-2-methyl-1-[p-(methylsulfinyl)-benzylidenyl] indene-3-acetic acid), an anti-inflammatory agent, was demonstrated in vitro by cell-free preparations of guinea pig liver. The sulfoxide reductase activity was located in both fractions of microsomes and 105000×g supernatant. The microsomal reductase was NADPH-or NADH-dependent, and required the factor present in the soluble fraction for its activity. The factor was heat-labile and non-dialyzable. Furthermore, a pattial purification of the microsomal NADPH-cytochrome c reductase resulted in a paralleled increase of the sulfoxide reductase activity. The present observations suggest that the soluble factor described above functions as an electron transfer component coupled with NADPH-cytochrome c reductase.
収録刊行物
-
- Journal of pharmacobio-dynamics
-
Journal of pharmacobio-dynamics 3 (6), 290-298, 1980-06
公益社団法人日本薬学会
- Tweet
キーワード
詳細情報 詳細情報について
-
- CRID
- 1570291227417328640
-
- NII論文ID
- 110003635897
-
- NII書誌ID
- AA00704585
-
- ISSN
- 0386846X
-
- 本文言語コード
- en
-
- データソース種別
-
- CiNii Articles